Orthocell Limited (ASX:OCC) has disclosed that director John Van Der Wielen acquired 90,000 ordinary shares on 9 November 2026 for consideration of $53,420.74, increasing his indirect holding through Bond Street Custodians Limited to 727,741 ordinary shares.

Key Points

  • Director John Van Der Wielen purchased 90,000 ordinary shares on 9 November 2026 via an on-market trade.
  • Total consideration paid for the acquired shares was $53,420.74.
  • The shares were acquired indirectly through Bond Street Custodians Limited, with Mr Van Der Wielen as a beneficiary of the custodian account.
  • Following the transaction, Mr Van Der Wielen holds 727,741 ordinary shares and 4,000,000 unlisted options exercisable at $0.40 each on or before 29 May 2028.

On-Market Share Purchase by Director

According to the filing lodged with ASX, director John Van Der Wielen completed an on-market purchase of 90,000 ordinary shares in Orthocell Limited on 9 November 2026. The total consideration for the transaction was $53,420.74. The purchase was not conducted during a closed period requiring prior written clearance. The previous date of notice for Mr Van Der Wielen's interests was recorded as 20 July 2026, with this filing reflecting the most recent update to his disclosed securities position in the company.

Director's Indirect Holding via Custodian Account

The 90,000 ordinary shares were acquired indirectly through Bond Street Custodians Limited, operating under the account reference CPCPL – V57757 A/C. The filing states that Mr Van Der Wielen is a beneficiary of the account held by the custodian. Prior to the change, the indirect holding stood at 637,741 ordinary shares. Following the on-market purchase, the indirect ordinary share holding increased to 727,741 shares, as disclosed in the Appendix 3Y change of director's interest notice submitted by Orthocell Limited.

Director's Remaining Options Position Unchanged

Alongside his ordinary share holding, Mr Van Der Wielen continues to hold 4,000,000 unlisted options exercisable at $0.40 each on or before 29 May 2028. This options position, held as a direct interest, was not affected by the 9 November 2026 transaction and remained unchanged at the same quantity recorded prior to the share acquisition. No securities were disposed of as part of the disclosed change. The filing confirms no interests in contracts were subject to change, with all Part 2 fields recorded as not applicable.